Best Compounded Tirzepatide Pharmacy 2026: 6 Ranked

By the GLP-1 US editorial team · Last reviewed: May 23, 2026 · About our review process

You searched “best compounded tirzepatide pharmacy” expecting to buy from a pharmacy. You can’t. Compounding pharmacies fill prescriptions. They don’t sell direct to patients. What you’re shopping is the telehealth providers that source from 503A and 503B pharmacies, and most won’t tell you which one.

We spent six months walking through each tirzepatide program in our review: timing shipments, opening boxes in summer, clicking cancel buttons, asking clinicians questions. Best compounded tirzepatide pharmacy in 2026 means picking the provider whose pharmacy partner you can name, whose dose-escalation refill workflow doesn’t add a week to every titration step, and whose cold-chain packaging actually keeps tirzepatide below the 86°F threshold Eli Lilly’s stability data sets.

The six providers below are ordered by lived patient experience for tirzepatide. Pomegranate Health scored 94 in our underlying audit, the highest of any provider, yet lands at #1 only with caveats most competitors hide. ShedRx ships from a pharmacy network that includes Strive (now in active antitrust litigation with Lilly and Novo Nordisk). RemedyMeds has a September 2025 FDA warning letter that specifically cites tirzepatide marketing claims. We name all of it.

Pricing is in this article. It’s just not at the top.

How We Ranked These Tirzepatide Providers (Patient-First Criteria)

The FDA logged 320+ adverse event reports for compounded tirzepatide through early 2025, per Pharmacy Times. Most were not contamination. They were dosing errors from patients drawing the wrong amount out of a multi-dose vial, some requiring hospitalization. A great tirzepatide provider has to make the program safe to inject, not just cheap to start.

Our seven patient-first criteria:

Pricing transparency before signup. Can you see the cost across the 20-week trajectory (2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg per SURMOUNT-1) before submitting personal info? Some stay flat (GobyMeds $299, Enhance.MD $329); others escalate by dose.
Pharmacy partner disclosure. GobyMeds, Pomegranate, Enhance.MD, ShedRx, and Peak Wellness name their 503A or 503B pharmacy. RemedyMeds does not.
Time to first shipment. Concrete hours from signup to medication in hand.
Refill workflow during dose escalation. Five dose-change conversations over 20 weeks. Async check-ins or 90-day cadences make this manageable. A new video visit per dose step adds 1-3 days of friction five times.
Cold-chain reliability. Per Eli Lilly stability data, tirzepatide tolerates room temperature (below 86°F) for up to 21 days; above 86°F the window closes immediately. Tirzepatide degrades faster with heat than semaglutide. Three ice packs in foam is the floor for summer.
Clinician response SLA. How fast a real human replies in the portal.
Cancellation experience. One-button portal exit, non-subscription, or a cancel button that routes to a mandatory phone call.

Regulatory backdrop. On April 30, 2026, the FDA published a proposed rule (91 Fed. Reg. 23431, docket 2026-08552) that would formally exclude tirzepatide, semaglutide, and liraglutide from the 503B Bulks List. Public comment period closes June 29, 2026. FDA’s rationale: “no clinical need” absent a shortage. Orrick calls it the move to “shut the door on large-scale compounding.” Section 503A’s “essentially a copy” rule still requires documented individual medical need (polysorbate 80 allergy, non-commercial dose strength, or other clinical reason) per Frier Levitt. Foley & Lardner clarified FDA will not pursue enforcement against 503A compounders filling four or fewer prescriptions per month.

Litigation moves in parallel. Eli Lilly has obtained 12+ permanent injunctions against compounders across 2025-2026. Eli Lilly v. Mochi Health was allowed to proceed in April 2026 by Judge Jacqueline Scott Corley (N.D. Cal.) on Lanham Act and California Unfair Competition Law claims tied to tirzepatide marketing. Strive Compounding Pharmacy, a ShedRx partner, filed a federal antitrust countersuit against Lilly and Novo Nordisk on January 14, 2026 (PR Newswire). Both are in our ranked roster.

We considered and demoted five providers:

Henry Meds. Tirzepatide injection not confirmed in our research. Only oral tablet at $597/3mo. Pharmacy partner Tailor Made Compounding LLC has a Kentucky permit expired March 2021 and a prior FDA plea agreement for unlawful interstate distribution.
Lemonaid Health. Cold-chain failure: soggy box, both ice packs fully melted. Bubble wrap only, no insulated foam.
Amble. Align Pharmacy LLC (Metairie, LA) license expired 2024, permanently closed. 126 BBB complaints with pattern alert.
IVYRx. Markets pharmacies as “503B / USP <797>” when the confirmed pharmacy (Greenwich RX) is 503A. Material misrepresentation.
LifeRx. DocuSign-required intake, 9 post-purchase text messages, magic-link portal that often fails. Pharmacy disclosed only on request.

Top Picks Comparison Table

Provider	Best For	Starting Price	Patient-First Score	Apply Now
Pomegranate	Cheapest Tirzepatide in the Audit, with the Most Pharmacy Options	$159/mo	86 / 100	See Offer
Goby Meds	The Transparency Leader for First-Time Tirzepatide Buyers	$299/mo	78 / 100	See Offer
ShedRx	Only Tirzepatide Microdose in the Roster, Best Cold-Chain for Heat-Sensitive Peptide	$299/mo	98 / 100	See Offer
Enhance.MD	Only Tirzepatide Provider with Mandatory Labs and Truly Flat Pricing	$329/mo	91 / 100	See Offer
Mochi Health	Best Native App for Tirzepatide, with Two Disclosures You Should Read	$278/mo	90 / 100	See Offer
RemedyMeds	Fastest Tirzepatide Shipping, with an FDA Letter You Must Read	$399/mo	95 / 100	—

1. Pomegranate Health: Cheapest Tirzepatide in the Audit, with the Most Pharmacy Options

Pomegranate scored 94/100 in our underlying audit, the highest of any provider. Its OptioRx tirzepatide starter at $159/month is the lowest tirzepatide price we tracked. So why does this article need a section to explain when to pick it? Because the audit isn’t the patient experience, and Pomegranate’s worst flaw shows up before you become a patient.

Pricing: $159/mo OptioRx starter (0-7.9 mg). $179/mo BPI Labs or Hallandale. $199/mo Empower. $299/mo RedRock. 6-month bundles drop to $569-$1,169. $150 coordination fee to specify the pharmacy. Non-subscription, never auto-charged.

Five tirzepatide pharmacies with selectable additives: BPI Labs (Pyridoxine B6), Empower (Niacinamide B3), Hallandale (no additive), RedRock (Glycine or B12), and OptioRx (Niacinamide B3). The multi-pharmacy network gives supply redundancy single-pharmacy providers cannot match, which matters more in a year when the April 30, 2026 FDA proposal could squeeze any one 503B supplier.

Patient-experience strengths:

$159/mo OptioRx starter is roughly half what RemedyMeds charges and a fraction of branded Zepbound cash-pay.
Monthly phone check-in with the provider. The only synchronous clinical touchpoint in our ranked roster.
Cold-chain shipping: 2 large non-sweat ice packs, tight foam wrap, medication jammed between packs. Holds tirzepatide well below 86°F in summer transit.
Interactive pricing tab lets you compare cost by pharmacy and dose before signup.
LegitScript certified, with full pharmacy licensing transparency across all five partners.

Patient-experience weaknesses (we lead with these):

Non-patient support is a circular loop. Reviewer note: “If you are not currently a patient you might find that you are sent on a loop trying to contact support and coming up unsupported.” Chat says log into portal. Portal says email support. Email directs to a different portal.
BBB F rating. 8 complaints, failure to respond.
Trustpilot 3.4 stars across 114 reviews.
Zero refunds on consults or medication (filled or not). $100 chargeback fee.
24-hour window to report pharmacy or delivery issues.
Portal runs on CharmHealth (dated, no in-portal tracking).
Chat SLA 12-24 hours. Phone goes to voicemail.

The verdict: cheapest legitimate compounded tirzepatide in the category, deepest pharmacy network, and the only ranked provider with a monthly phone check-in. If you can get through intake without needing help, Pomegranate’s ongoing experience is the best in our roster. If you need anyone to walk you through anything before paying, GobyMeds at $299/mo flat is the cleaner first-time buy.

2. GobyMeds: The Transparency Leader for First-Time Tirzepatide Buyers

GobyMeds is the only provider where you can pull up the pricing tab, pick a tirzepatide pharmacy, see which additive (Pyridoxine B6, niacinamide) is included, hover the additive for a tooltip, and decide whether to start, all before giving an email address. For a first-time tirzepatide buyer, that single UX choice solves the biggest information asymmetry in the category.

Pricing: $299/mo at every dose, 2.5 mg through 15 mg. $399 for a 3-month low-dose bundle. $499-$599 for 3-month higher-dose bundles. No membership fee. Non-subscription.

Pharmacy partners: CasaPharmaRx, SevenCells, VitalRx via PharmacyHub, BPI Labs via PharmacyHub. Pharmacy and additive selectable during intake with hover tooltips. CasaPharmaRx had 9 deficiencies in August 2025, all corrected by January 2026 (disclosed publicly).

Patient-experience strengths:

Flat $299/mo across all doses. No dose-escalation cost surprise across the 20-week titration.
24-hour delivery after shipment leaves the warehouse. Fastest from-shipment in our review.
Pricing and pharmacy visible pre-signup.
8-stage order tracker in the patient portal. Most granular we tested.
Detailed syringe-drawing guide included with shipments. Directly mitigates the leading adverse event mechanism (multi-dose vial draw errors).
Non-subscription, LegitScript certified, full pharmacy disclosure.

Patient-experience weaknesses:

Phone support is non-functional. Rings, hits voicemail, no callbacks observed.
Chat response 1-2 days, and the reply arrives via email rather than in-chat.
Refill workflow not documented in the portal. You have to message support to learn that the order window opens about two weeks before run-out and that “Start Check-in” activates it. Friction you feel five times.
Intake requires a full-body photo in tight clothing.
No tirzepatide microdose option.

Best for: First-time tirzepatide buyers who want price, pharmacy, and additive visible before committing. Patients who want flat pricing across the full titration.

Skip if: You need same-day phone support during a problem, or you want a tirzepatide microdose. Microdose tirzepatide lives at ShedRx.

3. ShedRx: Only Tirzepatide Microdose in the Roster, Best Cold-Chain for Heat-Sensitive Peptide

ShedRx is the only provider in our ranked roster that ships tirzepatide with three gel ice packs inside an insulated foam box. Most ship with one or two. Mochi ships with two thin plastic packs and no foam. Per Eli Lilly’s labeling, tirzepatide degrades faster with heat than semaglutide, and the 21-day room-temperature window closes the moment temperature exceeds 86°F (per Fella Health‘s review of Lilly stability data). For summer shipping, that ice pack count is real potency protection.

Pricing: $299 first month, $399/mo thereafter (escalates by dose). Tirzepatide oral drops $279-$419/mo. Tirzepatide microdose injection $199/mo, the only microdose tirzepatide in our ranked roster.

Pharmacy partners: Strive Pharmacy, Boothwyn Pharmacy, WP Pharma Labs, Red Rock Pharmacy, Promise Pharmacy, Everwell Pharmacy. Strive disclosure: Strive is a defendant in Eli Lilly’s compounding pharmacy litigation and filed a federal antitrust countersuit against Lilly and Novo Nordisk on January 14, 2026 (PR Newswire). Allegations include exclusive agreements with telehealth platforms and disruption of payment processor relationships. Strive is currently operational.

Patient-experience strengths:

Only tirzepatide microdose in our ranked roster at $199/mo. Meaningful for nausea-sensitive patients or ultra-slow titration below the 2.5 mg therapeutic floor.
Tirzepatide oral drops ($279-$419/mo). Compounded oral efficacy is weaker than injection, which we disclose plainly.
Best cold-chain in our review: 3 gel ice packs, insulated foam box, medication double-bagged.
Overnight shipping. Tracking in both email and portal.
90-day cadence option: 3 monthly refills before the next provider check-in.
100/100 Patient Support sub-score. AI phone support with detailed answers, human reachable on request.

Patient-experience weaknesses:

2-month minimum commitment buried in checkout fine print. No refunds within that window or if you cancel after the 3rd prescription is sent. Reviewer: “This is not super clear in checkout.”
Price escalates by dose ($299 first month, $399 thereafter). Different from GobyMeds flat $299 or Enhance.MD flat $329.
Pricing hidden until intake completion.
Video consultation required, adding 1-2 days to first shipment.
LegitScript Probationary only (prior non-compliance on record).
Strive pharmacy in active Eli Lilly litigation (above).

If you want tirzepatide microdose or oral drops, ShedRx is the only ranked option. If you’re a summer shopper or live in a hot-climate state, the 3-pack cold chain is the protection you want. If you’re not certain you’ll stay on tirzepatide for at least 60 days, the 2-month minimum is real money. Start at GobyMeds or Pomegranate instead.

4. Enhance.MD: Only Tirzepatide Provider with Mandatory Labs and Truly Flat Pricing

Enhance.MD’s patient portal has a large, prominent “Cancel” button. Click it and you get a message: “It’s necessary to speak with a customer service representative or medical assistant to finalize the closure of your medical chart.” Reviewer note: “I have to call anyway. That button felt like a trick.” That single UX deception is why Enhance.MD ranks #4 instead of #2 despite arguably the cleanest clinical model in our roster.

Pricing: $329/mo (1-month). $313/mo (3-month). $296/mo (6-month). $280/mo (12-month). Same price at every dose 2.5 mg through 15 mg. Spring introductory discount available.

Pharmacy partners: Rite-Away Pharmacy, Vios Compounding Pharmacy, TruMedsRx. Zero disciplinary history across all three. 100/100 Legitimacy sub-score.

Patient-experience strengths:

Only tirzepatide provider in our ranked roster requiring labs. Before month 2, then every 6 months. The most clinical model available in async telehealth.
Truly flat tirzepatide pricing across all doses. No escalation surcharge.
Phone support answered quickly by real humans (8 a.m.-8 p.m. EST). No AI gating. Chat responds in minutes.
FedEx Standard Overnight. Cold-chain: soft FedEx bubble pack, inner foam insulation, 1 large sweat-proof ice pack.
Also offers a semaglutide plus tirzepatide combination for patients who have plateaued.
BBB A+, Trustpilot 4.1.

Patient-experience weaknesses:

Cancel button routes to a mandatory phone call (above).
Not available in 10 states (AL, AR, GA, HI, LA, MS, MO, SC, TN, WV).
No tirzepatide microdose option.
No injection instructions or drug information in the box. Riskiest information gap in our review for first-time tirzepatide injectors, given the 320+ FDA-logged adverse events from vial draw errors.
HSA/FSA not accepted.
Video consultation required (20-minute initial).

Best for: Patients who want labs, clinical oversight, and a flat tirzepatide price across the full titration. Patients planning long-term therapy who can lock in the 12-month plan at $280/mo.

Skip if: You expect to shop providers. The cancel button is not really a button, and for tirzepatide, where you might cancel mid-titration due to GI side effects, that matters.

5. Mochi Health: Best Native App for Tirzepatide, with Two Disclosures You Should Read

Mochi ships your tirzepatide inside a branded metal water bottle (their merch). Two thin plastic ice packs sit loose around it. Our reviewer didn’t realize the peptides were inside the bottle and shook it to get the ice packs out. Reviewer quote: “It is not good to shake peptides, they are very fragile.” Tirzepatide is heat-sensitive per Lilly stability data and vulnerable to mechanical agitation per peptide chemistry. This packaging is a real protection gap.

True cost: $278/mo ($199 medication plus $79 required membership). All doses same price. Advertised “starting at $39/mo” refers to membership only.

Pharmacy partners: 7 Cells, Drug Crafters (likely more, since the patient can choose in-portal). Pharmacy name visible on the medication listing.

Eli Lilly litigation: Eli Lilly v. Mochi Health was allowed to proceed by Judge Jacqueline Scott Corley (N.D. Cal.) in April 2026 on Lanham Act false advertising and California Unfair Competition Law claims tied specifically to tirzepatide marketing. The civil conspiracy claim was dismissed; Lilly given leave to amend. Lilly has obtained 12+ permanent injunctions against other compounders. If Lilly wins an injunction against Mochi, Mochi may need to stop compounded tirzepatide sales. Mochi tirzepatide patients should identify a fallback provider now.

Patient-experience strengths:

Native iOS and Android app with dose tracking. The only ranked provider with a real native app.
In-portal pharmacy selection with the name visible. In-portal provider switching.
$199/mo medication is among the lowest in the portfolio (before membership).
Same provider at each video follow-up.
Insurance assistance for brand-name medications (Zepbound, Mounjaro).
HSA/FSA accepted. LegitScript certified.

Patient-experience weaknesses:

Weakest cold-chain in our roster (above), counter to tirzepatide’s heat sensitivity.
Eli Lilly litigation actively proceeding (above).
Advertised $39/mo is misleading; true all-in is $278/mo.
Cancel button may not fully cancel the membership. One customer received a cancellation email March 31, 2026, then was billed a new $79 service fee in April. Mochi initially refused the refund.
BBB pattern of complaints: missed medications, long phone holds, ignored messages.
Chat is for active patients only. Email response in testing: over a week.

If you want the best mobile app for tracking tirzepatide and you’re comfortable with the Eli Lilly litigation risk, Mochi is the only real app option. If you order in summer, request supplementary cold-chain from support before they ship, and confirm in writing how your membership cancels.

6. RemedyMeds: Fastest Tirzepatide Shipping, with an FDA Letter You Must Read

RemedyMeds offers same-day video consults (within 30 minutes of intake) and 1-day shipping. Total signup to first injection: 1-2 days. Fastest path in our review. It’s also the only provider in our ranked roster with a publicly verifiable FDA warning letter on file, and the letter specifically cites tirzepatide marketing claims.

Pricing: $399/mo, same price at every dose. No bundles. No membership fee. Highest tirzepatide monthly price in our portfolio. No microdose. No oral option. Month-to-month only.

The FDA disclosure: RemedyMeds received an FDA warning letter dated September 9, 2025, at fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/remedy-meds-716830-09092025. The letter specifically cited tirzepatide and semaglutide claims of “same active ingredient” as branded products. Whether the issues have been resolved is not publicly confirmed. Per Foley & Lardner and Frier Levitt, the 2026 FDA enforcement focus is marketing language. Warning letters are not automatic disqualifiers, but they are signals worth weighing, particularly for tirzepatide where Eli Lilly is litigating similar marketing claims against Mochi.

Pharmacy partner: not disclosed publicly. Phone support told our reviewer that compounded tirzepatide comes from “basically your local pharmacy,” which is inaccurate. Compounded tirzepatide is filled by 503A or 503B specialty pharmacies, not retail.

Patient-experience strengths:

1-day shipping. the fastest we reviewed.
Flat $399 across all doses.
Automated self-serve portal cancellation with a discount-offer flow and reactivation option.
Same-day video consultation.
24/7 support chat.
Rich patient portal: cooking videos, habit-building courses, expert events.
LegitScript certified.

Patient-experience weaknesses:

September 2025 FDA warning letter citing tirzepatide marketing claims (above).
Pharmacy partner not disclosed.
$399/mo is the highest tirzepatide price in our portfolio. $240/mo more than Pomegranate OptioRx.
No microdose.
BBB F rating. 11 complaints, failure to respond to 6.
Pricing visible only after intake.

Quick comparison with GobyMeds: RemedyMeds ships one day faster and offers same-day video consults, but withholds the pharmacy partner identity, has a 2025 FDA warning letter specific to tirzepatide marketing, and costs $100/mo more. GobyMeds is one day slower, shows pharmacy and additive at intake, has no warning letter, and is $100/mo cheaper. If pharmacy transparency matters more than 24 hours of speed, choose GobyMeds.

The Bottom Line: Which Compounded Tirzepatide Provider Is Right for You

Six providers ship compounded tirzepatide injection that survives our patient-first lens. Not one is right for everyone. Here’s how to pick by what matters most.

Cheapest tirzepatide: Pomegranate Health (OptioRx starter at $159/mo, multi-pharmacy network, monthly phone check-ins). Power through the pre-patient support loop.
First-time buyer wanting full pre-signup transparency: GobyMeds ($299/mo flat, pharmacy and additive visible during intake, syringe guide in box).
Microdose or oral drops: ShedRx ($199/mo microdose, $279/mo oral drops). The only ranked provider offering either.
Summer shopper or hot-climate state: ShedRx (3 ice packs in foam) or Pomegranate (2 large non-sweat packs). Avoid Mochi cold-chain.
Labs, clinical oversight, flat price across the full titration: Enhance.MD ($329/mo, or $280/mo on the 12-month plan). Plan to cancel by phone.
Real native app for dose tracking: Mochi Health. Weigh the Eli Lilly litigation and cold-chain disclosures.
Fastest shipping: RemedyMeds (1-day shipping, same-day video). Read the FDA warning letter first.

The April 30, 2026 FDA proposal to remove tirzepatide from the 503B Bulks List has a public comment period closing June 29, 2026. 503A patient-specific compounding is likely to continue with documented medical need. Current tirzepatide patients are not at immediate risk of losing access overnight, but the regulatory landscape is moving fast.

Price is one column. The other six are what this list ranked on. Pick the provider whose patient experience matches yours.

Frequently Asked Questions About Compounded Tirzepatide Pharmacies

Is compounded tirzepatide still legal to get in 2026?

Technically yes, but narrowed. 503B large-scale compounding has been restricted since March 2025 and faces permanent exclusion under the April 30, 2026 FDA proposed rule (91 Fed. Reg. 23431, comment period closes June 29, 2026). 503A patient-specific compounding remains lawful with documented individual medical need: polysorbate 80 allergy, non-commercial dose strength, or another prescriber-documented clinical reason. Foley & Lardner’s de minimis safe harbor permits four or fewer prescriptions per month per 503A compounder without enforcement action.

What is the FDA 503B Bulks List proposal and what does it mean for my tirzepatide?

The April 30, 2026 FDA proposed rule (91 Fed. Reg. 23431) would formally exclude tirzepatide from the list of drugs 503B outsourcing facilities can compound from bulk substances. If finalized after the June 29, 2026 comment period, large-scale 503B compounding of tirzepatide would be permanently prohibited. 503A patient-specific compounding with documented medical need could continue, and any final rule would include a transition period. Orrick projects final rule timing as early as Q4 2026.

What is the “essentially a copy” rule and does it affect compounded tirzepatide?

Under Section 503A, a compounder cannot produce a product “essentially a copy” of an FDA-approved drug without documented individual medical need. Compounded tirzepatide at a dose within ±10% of a commercial Mounjaro or Zepbound SKU (2.5, 5, 7.5, 10, 12.5, or 15 mg) by injection is considered essentially a copy, per Frier Levitt. Compounding to save money is not qualifying. Qualifying reasons: polysorbate 80 allergy, non-commercial dose strength (e.g., microdose), or another documented clinical reason.

How do I store compounded tirzepatide and what if it gets warm during shipping?

Store at 36°F-46°F (2°C-8°C), per Eli Lilly’s prescribing information. If it leaves the fridge, it can be kept below 86°F for up to 21 days. Above 86°F at any point, the 21-day window is voided. Freezing irreversibly damages the peptide. On a summer shipment, check that the ice pack is still cold, the vial is not warm, and there are no bubbles or particulate in solution. A fully melted ice pack means contact the pharmacy before injecting.

Does insurance cover compounded tirzepatide?

No. Compounded tirzepatide is cash-pay only. HSA and FSA cards are accepted at most ranked providers (GobyMeds, ShedRx, Mochi, Peak Wellness). Enhance.MD does not. Branded tirzepatide (Zepbound, Mounjaro) may be partially covered with prior authorization; Mochi offers insurance assistance for branded options.

Why is tirzepatide more heat-sensitive than semaglutide?

Per Eli Lilly’s stability data (via Fella Health’s review of Lilly labeling), tirzepatide’s peptide structure breaks down faster with heat than semaglutide’s. Both store at 36°F-46°F and allow room-temperature use below 86°F for 21 days. The practical difference shows up in summer shipping, where the gap between a 1-pack and 3-pack packaging system matters more for tirzepatide.

What’s the FDA warning letter situation for compounded tirzepatide providers?

Search the FDA database at fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters. Confirmed letters: RemedyMeds (September 9, 2025) citing tirzepatide and semaglutide “sameness” claims. Hims & Hers (September 2025) via MedisourceRx. GenoGenix (January 2026) for facility violations including three ER visits. The March 2026 wave issued 30 letters to telehealth firms for marketing claims. More than 135 total GLP-1 letters since September 2025.

Does Eli Lilly’s lawsuit against Mochi mean Mochi could stop offering tirzepatide?

Possible but not certain. Eli Lilly v. Mochi was allowed to proceed by Judge Corley (N.D. Cal.) in April 2026 on Lanham Act and California Unfair Competition Law claims tied to tirzepatide marketing. The civil conspiracy claim was dismissed; Lilly may amend. Lilly has obtained 12+ permanent injunctions against other compounders. If Lilly wins an injunction, Mochi may need to stop compounded tirzepatide sales. Current Mochi patients should identify a fallback provider.